Suzanne Marie Schofield, MA, LIMHP, LADC | |
132 S 30th St, Ashland, NE 68003-1462 | |
(402) 619-6077 | |
Not Available |
Full Name | Suzanne Marie Schofield |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 132 S 30th St, Ashland, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700485976 | NPI | - | NPPES |
1452 | Other | NE | LADC |
3048 | Other | NE | LIMHP |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 3048 (Nebraska) | Secondary |
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Suzanne Marie Schofield, MA, LIMHP, LADC 132 S 30th St, Ashland, NE 68003-1462 Ph: (402) 619-6077 | Suzanne Marie Schofield, MA, LIMHP, LADC 132 S 30th St, Ashland, NE 68003-1462 Ph: (402) 619-6077 |
News Archive
Physicians should be alert to urinary problems in women with hyperthyroidism, say researchers who found an association between the endocrine disorder and bladder pain syndrome/interstitial cystitis.
Prana Biotechnology today announced it has entered into agreements to raise approximately A$7.77 million (US$6 million) from new institutional investors in Australia, existing institutional investors in the United States and a founding member of the Company.
An approach to treatment that focuses on recovery from mental illness, not the treatment of it, is gaining national acclaim for the Medical College of Georgia Department of Psychiatry and Health Behavior at Georgia Health Sciences University.
Cardiovascular Systems, Inc., has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of CSI's Diamondback 360® System in the coronary arteries. CSI received conditional IDE approval for the ORBIT II study in January 2010.
Texas Tech University Health Sciences Center researcher Afzal A. Siddiqui, Ph.D., a Grover E. Murray Distinguished Professor at the TTUHSC School of Medicine, received a $3.82 million grant from the National Institutes of Health (NIH).
› Verified 8 days ago